How Azzur Group Helped Prevent a Product Shortage through Validation and Qualification of an Existing Facility

In 2017, a top 20 global biopharmaceutical company faced the challenge of modifying and validating an existing facility to house the production of an injectable prescription medication. To avoid a product shortage, the client needed to have the facility ready for operation by the year 2023. Azzur’s team of consultants actively partnered with them to determine and drive a strategy that would have the facility fully validated and running by the deadline. 

For more information about how Azzur Group's team can help your organization with the commissioning, qualification, and validation of your facility, contact us today.